ProQR Therapeutics (PRQR) Change in Working Capital (2013 - 2026)
ProQR Therapeutics (PRQR) posted Change in Working Capital of -$127611.3 for Q1 2026, up 96.45% sequentially from -$3.6 million in Q3 2025, and down 101.81% YoY from $7.1 million in Q1 2025.
ProQR Therapeutics (PRQR) Change in Working Capital (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Change in Working Capital for 14 years, with the latest figure at -$127611.3 in Q1 2026.
- Quarterly Change in Working Capital fell 101.81% year-over-year to -$127611.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 44.3% YoY) and the FY2023 annual result came in at -$52.7 million, down 11554.26% from the prior year.
- Change in Working Capital improved to -$127611.3 in Q1 2026 per PRQR's latest filing, from -$3.6 million in the prior quarter.
- Over five years, Change in Working Capital peaked at $56.1 million in Q1 2023 and troughed at -$102.9 million in Q4 2023.
- A 5-year average of -$2.9 million and a median of $977423.9 in 2022 frame the typical range for Change in Working Capital.
- The widest YoY moves for Change in Working Capital: up 1166.01% in 2023, down 9834.52% in 2023.
- Over 5 years, Change in Working Capital stood at -$1.0 million in 2022, then plunged by 9834.52% to -$102.9 million in 2023, then jumped by 101.19% to $1.2 million in 2024, then sank by 392.95% to -$3.6 million in 2025, then surged by 96.45% to -$127611.3 in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$127611.3, -$3.6 million, and $1.3 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | -127,611.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127,611.28 |
| Mar 31, 2026 | -127,611.28 |
| Sep 30, 2025 | -3.59 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 7.07 Mn |
| Mar 31, 2025 | 7.07 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 4.97 Mn |
| Mar 31, 2024 | -10.02 Mn |
| Mar 31, 2024 | -10.02 Mn |
| Dec 31, 2023 | -102.88 Mn |
| Dec 31, 2023 | -102.88 Mn |
| Sep 30, 2023 | -2.19 Mn |
| Sep 30, 2023 | -2.19 Mn |
| Jun 30, 2023 | -3.94 Mn |
| Jun 30, 2023 | -3.94 Mn |